# Octave Specialty Group Inc: filings

OSG · NYSE · CIK 874501 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/osg.md) · [Financials](/companies/osg/financials.md) · [Filings](/companies/osg/filings.md) · [Insiders](/companies/osg/insiders.md)

## Reports and events: 304 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 589, 8-K 210, 10-Q 53, DEFA14A 35, SC 13G/A 29, 3 26, UPLOAD 25, CORRESP 23, 10-K 18, DEF 14A 17, 4/A 16, SC 13G 12, DFAN14A 10, SCHEDULE 13G/A 9, ARS 7, PREC14A 6, 25-NSE 5, S-8 POS 5, SCHEDULE 13G 5, 3/A 4, NT 10-Q 4, S-8 4, 11-K 3, 8-A12B 3, PRRN14A 3, 10-K/A 2, 10-Q/A 2, 25 2, 8-K/A 2, DEFC14A 2, PRE 14A 2, S-3ASR 2, 144 1, 15-12B 1, 5 1, 5/A 1, CERT 1, CERTNAS 1, CERTNYS 1, DEFM14A 1, DEFR14A 1, DEL AM 1, NO ACT 1, NT 10-K 1, NT 11-K 1, PREM14A 1, RW 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 17:03 ET | [10-Q](/filings/0001628280-26-054446.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054446 |
| 2026-08-06 | 16:58 ET | [8-K](/filings/0001628280-26-054440.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054440 |
| 2026-05-29 | 16:56 ET | [8-K](/filings/0001628280-26-039234.md) | 5.07 Shareholder vote results | 0001628280-26-039234 |
| 2026-05-06 | 16:50 ET | [10-Q](/filings/0001628280-26-031393.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031393 |
| 2026-05-06 | 16:41 ET | [8-K](/filings/0001628280-26-031377.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031377 |
| 2026-04-10 | 16:10 ET | [DEF 14A](/filings/0001628280-26-024684.md) | Proxy statement, period 2025-12-31 | 0001628280-26-024684 |
| 2026-04-07 | 16:08 ET | [8-K](/filings/0001628280-26-024072.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-024072 |
| 2026-03-04 | 16:29 ET | [10-K](/filings/0001628280-26-014653.md) | Annual report, period 2025-12-31 | 0001628280-26-014653 |
| 2026-02-23 | 16:19 ET | [8-K](/filings/0001628280-26-010639.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-010639 |
| 2026-01-06 | 16:03 ET | [8-K](/filings/0001628280-26-000870.md) | 9.01 Financial statements and exhibits | 0001628280-26-000870 |
| 2025-12-15 | 16:18 ET | [8-K](/filings/0001628280-25-057024.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001628280-25-057024 |
| 2025-11-10 | 17:20 ET | [8-K](/filings/0001628280-25-051169.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-25-051169 |
| 2025-11-10 | 16:57 ET | [10-Q](/filings/0001628280-25-051136.md) | Quarterly report, period 2025-09-30 | 0001628280-25-051136 |
| 2025-11-10 | 16:13 ET | [8-K](/filings/0001628280-25-051048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-051048 |
| 2025-11-03 | 08:38 ET | [8-K](/filings/0001628280-25-047943.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-047943 |
| 2025-09-30 | 16:06 ET | [8-K](/filings/0001628280-25-043221.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-043221 |
| 2025-09-29 | 17:07 ET | [8-K](/filings/0001628280-25-043138.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-043138 |
| 2025-09-29 | 17:06 ET | [8-K](/filings/0001628280-25-043137.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-043137 |
| 2025-09-29 | 16:16 ET | [8-K](/filings/0001628280-25-043087.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-043087 |
| 2025-08-07 | 16:54 ET | [10-Q](/filings/0000874501-25-000132.md) | Quarterly report, period 2025-06-30 | 0000874501-25-000132 |
| 2025-08-07 | 16:27 ET | [8-K](/filings/0000874501-25-000131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000874501-25-000131 |
| 2025-07-07 | 08:35 ET | [8-K](/filings/0001193125-25-155881.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-155881 |
| 2025-06-16 | 16:28 ET | [8-K](/filings/0000874501-25-000100.md) | 1.01 Entry into a material agreement | 0000874501-25-000100 |
| 2025-05-30 | 10:18 ET | [8-K](/filings/0000874501-25-000095.md) | 5.07 Shareholder vote results | 0000874501-25-000095 |
| 2025-05-12 | 17:09 ET | [10-Q](/filings/0000874501-25-000086.md) | Quarterly report, period 2025-03-31 | 0000874501-25-000086 |
| 2025-05-12 | 16:15 ET | [8-K](/filings/0000874501-25-000084.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000874501-25-000084 |
| 2025-04-11 | 07:56 ET | [DEF 14A](/filings/0000874501-25-000078.md) | Proxy statement, period 2024-12-31 | 0000874501-25-000078 |
| 2025-03-06 | 16:30 ET | [10-K](/filings/0000874501-25-000032.md) | Annual report, period 2024-12-31 | 0000874501-25-000032 |
| 2025-02-26 | 17:25 ET | [8-K](/filings/0000874501-25-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000874501-25-000015 |
| 2024-11-12 | 16:21 ET | [10-Q](/filings/0000874501-24-000245.md) | Quarterly report, period 2024-09-30 | 0000874501-24-000245 |
| 2024-11-12 | 16:15 ET | [8-K](/filings/0000874501-24-000244.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000874501-24-000244 |
| 2024-10-16 | 16:08 ET | [8-K](/filings/0000874501-24-000238.md) | 5.07 Shareholder vote results | 0000874501-24-000238 |
| 2024-09-17 | 16:25 ET | [8-K](/filings/0000874501-24-000211.md) | 9.01 Financial statements and exhibits | 0000874501-24-000211 |
| 2024-09-04 | 16:14 ET | [8-K](/filings/0000874501-24-000208.md) | 7.01 Regulation FD disclosure | 0000874501-24-000208 |
| 2024-08-06 | 16:27 ET | [8-K](/filings/0000874501-24-000178.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000874501-24-000178 |
| 2024-08-05 | 17:16 ET | [8-K](/filings/0000874501-24-000174.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000874501-24-000174 |
| 2024-08-05 | 16:24 ET | [10-Q](/filings/0000874501-24-000172.md) | Quarterly report, period 2024-06-30 | 0000874501-24-000172 |
| 2024-08-05 | 16:13 ET | [8-K](/filings/0000874501-24-000171.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000874501-24-000171 |
| 2024-08-02 | 17:25 ET | [8-K](/filings/0000874501-24-000166.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000874501-24-000166 |
| 2024-08-02 | 17:12 ET | [8-K](/filings/0000874501-24-000164.md) | 9.01 Financial statements and exhibits | 0000874501-24-000164 |
| 2024-06-13 | 09:52 ET | [8-K](/filings/0000874501-24-000144.md) | 7.01 Regulation FD disclosure | 0000874501-24-000144 |
| 2024-06-07 | 16:03 ET | [8-K](/filings/0000874501-24-000141.md) | 5.07 Shareholder vote results | 0000874501-24-000141 |
| 2024-06-05 | 16:40 ET | [8-K](/filings/0000874501-24-000139.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000874501-24-000139 |
| 2024-06-05 | 16:37 ET | [8-K/A](/filings/0000874501-24-000137.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000874501-24-000137 |
| 2024-06-05 | 07:20 ET | [8-K](/filings/0000874501-24-000131.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000874501-24-000131 |
| 2024-05-06 | 16:14 ET | [10-Q](/filings/0000874501-24-000128.md) | Quarterly report, period 2024-03-31 | 0000874501-24-000128 |
| 2024-05-06 | 16:11 ET | [8-K](/filings/0000874501-24-000127.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000874501-24-000127 |
| 2024-04-26 | 06:56 ET | [DEF 14A](/filings/0000874501-24-000119.md) | Proxy statement, period 2023-12-31 | 0000874501-24-000119 |
| 2024-02-27 | 16:15 ET | [10-K](/filings/0000874501-24-000040.md) | Annual report, period 2023-12-31 | 0000874501-24-000040 |
| 2024-02-27 | 16:07 ET | [8-K](/filings/0000874501-24-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000874501-24-000039 |

Page 1 of 7. [Older](/companies/osg/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:35 ET. No prices; not investment advice.